Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will hold a webinar on the global cannabis regulatory landscape on Thursday, May 19, at 4:00 p.m. EDT.
Additionally, the Company announced that their newly appointed VP of Regulatory Affairs, Holly Bell, will be speaking at Florida’s Industrial Hemp Conference and Exhibition. The conference is focused on advancing the industrial hemp industry in Florida and across the US. Bell will present an overview of Florida’s hemp program, which she helped leading state regulators develop. Those interested in attending may register at the link below.
Florida Industrial Hemp Conference and Exhibition:
Flora will host the State of Play: Cannabis Regulatory Landscape webinar on Thursday, May 19, at 4:00 p.m. EDT. During this live event, newly appointed VP of Regulatory Affairs Holly Bell, COO Jason Warnock and President and CEO Luis Merchan will explore the nuances of working within the global cannabis regulatory framework. The discussion will include an overview of the opportunities and challenges for Flora and other cannabis companies operating in the United States, Colombia and other global markets and the importance of working closely with government entities. Other topics of discussion will include what to expect from key bills that will increase accessibility and market opportunities for the Company and which markets continue to show substantial promise. All those interested in attending are encouraged to register using the link below. Questions can be submitted during the live stream event.
About Flora Growth Corp.
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the most extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; our environmental and sustainability practices and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517006224/en/
+1 (858) 221-8001